Loading
·
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
The quarterly reports for this company are not available yet. Please check back later.
In the mean time, check out some related stocks.